Merck Cash Flow from Operating Activities 2010-2024 | MKKGY
Merck annual/quarterly cash flow from operating activities history and growth rate from 2010 to 2024. Cash flow from operating activities can be defined as a company's cash flows from operations.
- Merck cash flow from operating activities for the quarter ending June 30, 2024 was $2.042B, a 26.95% increase year-over-year.
- Merck cash flow from operating activities for the twelve months ending June 30, 2024 was $10.233B, a 0.44% decline year-over-year.
- Merck annual cash flow from operating activities for 2023 was $4.095B, a 8.73% decline from 2022.
- Merck annual cash flow from operating activities for 2022 was $4.487B, a 17.83% decline from 2021.
- Merck annual cash flow from operating activities for 2021 was $5.461B, a 37.5% increase from 2020.
Merck Annual Cash Flow Ops
(Millions of US $) |
| 2023 |
$4,095 |
| 2022 |
$4,487 |
| 2021 |
$5,461 |
| 2020 |
$3,972 |
| 2019 |
$3,199 |
| 2018 |
$2,621 |
| 2017 |
$3,047 |
| 2016 |
$2,786 |
| 2015 |
$2,436 |
| 2014 |
$3,596 |
| 2013 |
$2,956 |
| 2012 |
$3,179 |
| 2011 |
$ |
| 2010 |
$ |
| 2009 |
$ |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-DRUGS |
$21.254B |
$22.719B |
|
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
|
